Expected number of incremental infections and deaths avoided in the U.S. under different trial designs, vaccine efficacies, and epidemiological scenarios, assuming trials start on August 1, 2020, superiority testing, and 10M doses of a vaccine per day are available after licensure, compared to the baseline case in which no vaccine is ever approved.
收藏NIAID Data Ecosystem2026-03-12 收录
数据链接：
官方服务：
资源简介：
Expected number of incremental infections and deaths avoided in the U.S. under different trial designs, vaccine efficacies, and epidemiological scenarios, assuming trials start on August 1, 2020, superiority testing, and 10M doses of a vaccine per day are available after licensure, compared to the baseline case in which no vaccine is ever approved.
创建时间：
2020-12-23
